Down-regulation of glial fibrillary acidic protein expression during acute lytic varicella-zoster virus infection of cultured human astrocytes.
The effects of the varicella-zoster virus (VZV) OKA vaccine strain in producing morphologic and antigenic changes in dissociated cultures of human fetal brain was investigated. Cultures containing 80% glial acidic fibrillary protein (GFAP), GFAP+ (positive) astrocytes and 20% GFAP- (negative) fibroblastic-like cells were infected with cell-free VZV OKA at a multiplicity of infection of 0.1 plaque-forming units per cell. Cytopathic effects and significant viral antigen labeling with antibodies against VZV gpl and immediate-early (IE) protein 62 were first detected 6 to 7 days postinfection. Several observations indicated that astrocyte GFAP expression was altered and diminished as a result of VZV infection itself, thereby raising doubts about the utility of combining cell markers and viral antigenic labeling in assessing the susceptibility of neural cell types to viral infection. The down-regulation of GFAP expression by VZV appears to be mediated by early rather than late events in the viral replication cycle and may not be the result of virally induced global shut-off of host cell protein synthesis. Similar observations were made using VZV Ellen, a multipassaged, nonvaccine strain. These observations have potential in vivo implications related to histologic analysis of VZV-infected tissues and disease pathogenesis.
Medical Virology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.
P G
PG
Kennedy
E O
EO
Major
R K
RK
Williams
S E
SE
Straus
D001253:Astrocytes / Q000378:metabolism / Q000473:pathology / Q000821:virology*; D002478:Cells, Cultured; D019433:Chickenpox Vaccine; D003588:Cytopathogenic Effect, Viral; D015536:Down-Regulation; D005333:Fetus; D005904:Glial Fibrillary Acidic Protein / Q000096:biosynthesis*; D014645:Herpesvirus 3, Human / Q000502:physiology*; D006801:Humans; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*; D014765:Viral Vaccines
D019433:Chickenpox Vaccine; D005904:Glial Fibrillary Acidic Protein; D009419:Nerve Tissue Proteins; D014765:Viral Vaccines